Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib and Paclitaxel in Platinum Resistant Ovarian Cancer
NCT01644825Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2010
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in ovarian cancer, sponsored by National Cancer Institute. Started Dec 2010; status: completed.
02
Drugs
pazopanib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01644825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01644825.